In this issue:
Meningeal inflammation and cortical demyelination in acute MS
Vitamin D and NFL in MS
DMT escalation leads to fewer relapses
Detecting optic nerve lesions in CIS and MS
Alemtuzumab vs fingolimod in RRMS after natalizumab cessation
CD19+ B-cells as a marker for clinical outcome in patients treated with rituximab
Ocrelizumab reduces progression of upper extremity impairment in PPMS
USPIO-positive MS lesions are associated with tissue damage
Genetic risk factors for paediatric-onset MS
Safety of cladribine
Please login below to download this issue (PDF)